Closing the perimenopause gap: what an advanced blood test can tell you in your 30s and 40s
You're sleeping eight hours and waking up exhausted. Your weight has shifted without any obvious reason. You walk into a room and forget why you're there. Your period is still arriving, mostly on time, and every blood test comes back "normal."
So you wonder if you're just stressed, or not exercising enough, or getting older. You carry on.
If this sounds familiar to you, this article is for you. It's a confirmation that what you're feeling is real, it has a biological explanation, and you are not imagining it.
These symptoms can be the opening act of perimenopause, and perimenopause can begin a decade or more before your last period [1]. The average age of natural menopause is approximately 51 in high-income countries [2]. That means that the hormonal shifts that could result in insomnia, brain fog, fatigue, mood changes, night sweats and unexplained weight gain can start years before the word "menopause" would cross your mind.
To understand whether these symptoms could be related to hormonal changes, specifically menopause, is something that we can test.
What perimenopause actually is, and when it starts
The clinical definition of menopause is crystal clear: 12 consecutive months without a period. Everything leading up to it is perimenopause.
Most people underestimate how long that transition lasts. For some women it's two to three years. For others, it stretches to eight or ten [3]. There are two broad phases, and understanding them helps explain why symptoms can appear so early and vary so much between women.
In early perimenopause, cycles begin to shift: arriving a little earlier or later than usual, changing in flow, becoming less predictable. Ovulation becomes inconsistent. Many women don't notice anything dramatic at this stage. In late perimenopause, periods start to be skipped entirely. Cycles stretch out. Hormonal changes become more pronounced and symptoms tend to intensify [1].
Throughout this process, estrogen and progesterone decline, but not at a smooth consistent rate. Sometimes estrogen spikes higher than it ever has; other times it drops sharply. Follicle-stimulating hormone (FSH) begins to rise as the body works harder to trigger ovulation. These oscillations are what produce the symptoms. And because the pattern is irregular, a single hormone measurement taken on the wrong day can look entirely normal.
When does perimenopause typically begin? The average age of natural menopause is approximately 51 [2], and most women enter the perimenopausal transition in their mid to late 40s. But research shows that hormonal changes can be underway well before cycles become visibly irregular. A large observational study published in JAMA Internal Medicine found that vasomotor symptoms (i.e., hot flashes, night sweats) lasted a median of 7.4 years across the menopausal transition, with significant variation among women [3]. For a subset of participants, hormonal shifts were detectable before any measurable change in cycle regularity, with symptoms such as sleep disruption and mood changes appearing in the late 30s [4]. Early onset perimenopause, defined as beginning before age 40, is less common (around 10% of women) but clinically important and should be taken seriously rather than attributed automatically to stress [4].
The symptoms: what perimenopause feels like
Perimenopause doesn't announce itself with a single, unmistakable sign. It arrives as a collection of changes, many of which overlap with stress, aging, or other conditions, which is exactly why they go unrecognized for so long. Understanding the full range of symptoms is the first step toward seeking answers.
Changes to your cycle
This is the textbook early sign, and the one most likely to be noticed first. Your periods may arrive earlier or later than expected. They may become heavier, lighter, or both, alternating unpredictably from month to month. You may skip a cycle entirely, then have two heavy ones in a row. These changes reflect the hormonal volatility underneath: as ovulation becomes inconsistent, the signals that regulate your cycle lose their rhythm [1].
If your periods have always been predictable and they start behaving differently in your late 30s or 40s, this is worth paying attention to, even if it's the only symptom you notice.
Hot flashes and night sweats
These are the symptoms most commonly associated with menopause in the public imagination, but they often begin during perimenopause, sometimes years before your last period [3]. A hot flash is a sudden wave of heat, often starting in the chest and rising to the face and neck, lasting seconds to minutes. Night sweats are the same mechanism playing out during sleep.
The cause involves estrogen's role in thermoregulation. As estrogen fluctuates, the hypothalamus (your body's thermostat) becomes more reactive, narrowing the thermoneutral zone, the range of core body temperatures it considers "normal." Even small shifts trigger a heat-dissipation response: flushing, sweating, and a racing heart [5]. Some women experience night sweats before they're dramatic enough to soak through sheets, and dismiss them as sleeping too warm. But the pattern is hormonal, and it's measurable.
Sleep disruption
Difficulty falling asleep, staying asleep, or waking at 3am with a racing heart are among the earliest and most common perimenopausal symptoms [6]. Even without noticeable night sweats, fluctuating estrogen disrupts the architecture of sleep by interfering with serotonin production and temperature regulation. The result is fragmented sleep that leaves you exhausted in a way that coffee doesn't fix.
This symptom is routinely attributed to stress or anxiety. It often is both, but the hormonal contribution goes unmeasured.
Fatigue that isn't explained by sleep
Even if you're sleeping reasonably well, you may notice a particular kind of perimenopausal fatigue: a heaviness that arrives mid-afternoon, a reduced capacity to recover from exercise, a sense that the energy available to you has quietly contracted. Progesterone has a calming, mildly sedative effect. As it falls, that buffer disappears. At the same time, fluctuating thyroid function, which is more common during the perimenopause transition, can compound fatigue significantly [4]. A full hormone panel distinguishes between these causes; a standard blood panel typically does not include these markers.
Mood changes, anxiety, and depression
This is one of the most significant and most under-discussed aspects of perimenopause. Estrogen modulates serotonin, dopamine, and norepinephrine, the neurotransmitters that regulate mood, motivation, and emotional resilience. When estrogen fluctuates sharply, you may experience irritability that feels disproportionate, anxiety that arrives without a clear trigger, or a low mood that doesn't respond to the things that usually help.
Research consistently shows that the perimenopausal transition carries an elevated risk of new-onset depression, particularly in women with a prior history of mood disorders or premenstrual sensitivity [7]. This is not about being "emotional" or "not coping." It's neurochemistry, and it has a measurable hormonal correlate.
If you've always been emotionally steady and something has shifted, this deserves investigation.
Brain fog
Estrogen has receptors throughout the brain. It supports memory consolidation, processing speed, and cognitive flexibility. When estrogen fluctuates sharply, you may notice word-finding difficulties, trouble concentrating, and a sense that your thinking is slower or less reliable than it used to be. In research settings, perimenopausal and postmenopausal women show measurable changes in verbal memory performance that correspond to hormonal fluctuation and tend to stabilize after the transition [8].
This is one of the most distressing symptoms and one of the most poorly validated in routine care. "Brain fog" is not a diagnosis. But it has a biological basis, and naming it matters.
Weight gain, especially around the abdomen
Estrogen influences where fat is stored. Before menopause, it promotes fat distribution around the hips and thighs. As estrogen declines, fat preferentially accumulates around the abdomen, the pattern associated with increased cardiovascular and metabolic risk [4]. This shift happens regardless of changes in diet or exercise. You may be doing everything "right" and still watch your waist measurement increase.
Cortisol compounds this. Disrupted sleep raises cortisol. Elevated cortisol promotes abdominal fat storage and drives insulin resistance. The hormonal cascade is interconnected in ways that a single measurement will miss.
Vaginal dryness and urinary changes
Estrogen maintains the thickness, elasticity, and moisture of vaginal and urethral tissue. As estrogen declines, you may experience vaginal dryness, discomfort during intercourse, or an increased frequency of urinary tract infections. The medical term for this cluster of symptoms is genitourinary syndrome of menopause (GSM), a consensus term adopted in 2014 by the International Society for the Study of Women's Sexual Health and the North American Menopause Society [9]. GSM can begin during perimenopause, often earlier than expected.
These symptoms are underreported because many women find them difficult to bring up, even with their doctor. But they are common, treatable, and an important part of the clinical picture.
Changes in libido
Your interest in sex may shift, and not always in a single direction. Some women experience a noticeable decline in desire, which is closely linked to falling testosterone and DHEA-S levels as well as vaginal discomfort. Others describe fluctuations that mirror the hormonal volatility of the transition itself. Understanding your hormone levels helps distinguish between causes and guides targeted support.
Joint and muscle pain
This one surprises many women. Estrogen has anti-inflammatory properties and supports joint lubrication. As levels decline, you may develop new aches in your hands, knees, shoulders, or hips. Stiffness that's worse in the morning and doesn't respond to the usual stretches. If you're being investigated for early arthritis but the tests keep coming back inconclusive, a hormonal contribution is worth considering [4].
Headaches and migraines
If you have a history of menstrual migraines, perimenopause may make them worse or change their pattern. Even women who've never had significant headaches sometimes develop them during the transition, driven by the sharp hormonal drops that occur as estrogen fluctuations become more extreme [5].
Why standard blood tests miss it
The reason many perimenopausal women receive a "normal" result comes down to which markers are tested and when.
A standard blood panel for fatigue or sleep problems typically covers basic metabolic markers and thyroid function (TSH). Hormone testing is not automatically included. When hormones are checked, FSH is usually the marker ordered. During early perimenopause, FSH can still fall within the normal reference range on many days, because it rises unevenly rather than in a steady climb [1]. Estradiol behaves similarly: it can temporarily read higher than expected on some days before trending downward over time. A test taken on the wrong day of the cycle can read as normal even while hormones are actively shifting.
Reference ranges add another layer of complexity. The thresholds commonly used to flag "low estrogen" are calibrated for postmenopausal women. A woman in early perimenopause, whose estrogen is fluctuating rather than simply low, may not cross that threshold on the day she tests, even if her levels are changing significantly.
A comprehensive panel looks at a broader set of markers, including estradiol, FSH, LH, progesterone, SHBG, and thyroid function, and considers them together with cycle timing in mind. That fuller picture is what makes the results meaningful.
What a comprehensive hormone panel actually measures
A well-constructed hormone panel for a woman in her late 30s to mid-40s concerned about perimenopausal symptoms should include:
| Marker | What it is | What it tells you |
|---|---|---|
| Estradiol (E2) | The primary form of estrogen produced by the ovaries | Whether estrogen is fluctuating, declining, or within expected range for your age and cycle phase |
| FSH | A hormone released by the pituitary gland to stimulate the ovaries | Rising FSH is one of the early signs that the ovaries are responding to declining egg reserve |
| LH | A hormone that triggers ovulation | Helps assess ovulatory function alongside FSH; the LH/FSH ratio adds further context |
| Progesterone | A hormone produced after ovulation | Low progesterone in the luteal phase can explain mood symptoms, sleep disruption, and cycle irregularity |
| SHBG | A protein that binds sex hormones, including estrogen and testosterone | High SHBG reduces the amount of free, active hormone available to tissues |
| Testosterone | Produced in smaller amounts in women by the ovaries and adrenal glands | Declining testosterone is linked to reduced libido, energy, and muscle maintenance |
| DHEA-S | An adrenal hormone and precursor to estrogen and testosterone | Provides context for androgen levels; declines with age and under chronic stress |
| TSH and fT4 | Thyroid hormones | Thyroid dysfunction shares many symptoms with perimenopause and should be ruled out or identified alongside hormone testing |
| Vitamin D | A fat-soluble hormone-like nutrient | Deficiency is widespread in Switzerland and compounds fatigue, mood, and bone health concerns |
| AMH | A marker of ovarian reserve produced by follicles | Gives an indication of remaining egg supply and can help contextualize where you are in the reproductive transition |
Timing matters: where possible, testing in the early follicular phase (days 2 to 5 of your cycle) gives the most interpretable baseline for FSH and estradiol. Your physician can guide this.
You have your results. Now what?
Receiving clarity about where your hormones stand is a major turning point. It is not a diagnosis to fear; it's the data you need to act. The goal is not to "fix" a natural transition, but to manage the symptoms, protect your long-term health, and restore quality of life. Treatment is highly personal and depends on your symptoms, their severity, and your goals. It often involves a combination of approaches.
Hormone replacement therapy (HRT)
HRT is the most effective treatment for vasomotor symptoms (hot flashes and night sweats), and to prevent osteoporosis. It can also improve sleep, mood, vaginal dryness, and joint pain [11]. Modern HRT uses bioidentical hormones at lower doses than the formulations that generated headlines two decades ago. For women under 60, or within ten years of menopause, current evidence from bodies including the International Menopause Society supports a favorable benefit-risk profile, particularly for bone and cardiovascular protection [11].
HRT is not right for everyone, and the decision involves your personal medical history, risk factors, and preferences. But it should be part of the conversation, not excluded from it by default. Your GP or gynecologist can assess whether it's appropriate for you, and your hormone panel gives them the data to guide that decision.
Resistance training and exercise
This is not generic "stay active" advice. Resistance training (lifting weights, using bands, bodyweight exercises) is one of the most evidence-based interventions for the perimenopausal transition. It protects bone density as estrogen declines [10], preserves and builds muscle mass (which counteracts the metabolic shift toward abdominal fat), improves insulin sensitivity, and has well-documented effects on mood and sleep quality. If you're not already doing resistance training two to three times a week, perimenopause is the time to start.
Cardiovascular exercise remains important for heart health, but it is not sufficient on its own to counteract the musculoskeletal and metabolic changes of this transition.
Nutrition
No single diet "fixes" perimenopause, but the evidence supports an anti-inflammatory pattern: adequate protein (particularly important for preserving muscle), omega-3 fatty acids, calcium, and a reduction in ultra-processed foods and alcohol. Some women find that phytoestrogen-rich foods (soy, flaxseed) help with vasomotor symptoms, though the evidence is modest. A nutritionist or dietitian can help you make targeted changes rather than overhauling everything at once.
Targeted supplementation
Creatine might seem like an unexpected entry here, but the research connecting creatine supplementation to health outcomes relevant to the menopausal transition is more substantive than its gym-culture reputation suggests. Creatine supports cellular energy production via the phosphocreatine system, and the brain is one of the most energy-demanding organs in the body. A systematic review of randomized controlled trials found that creatine supplementation improves cognitive performance, particularly in contexts of stress or sleep deprivation [12]. A review published in Nutrients highlighted creatine's potential benefits across the female lifespan, including for bone density, muscle preservation, and mood in women over 40, particularly when combined with resistance training [13]. A meta-analysis of older adults found that creatine combined with resistance training produced greater gains in lean tissue mass and muscular strength than training alone [14].
Vitamin D supplementation is important for women in Switzerland, where deficiency and insufficiency are widespread — population-based data suggest that the majority of Swiss adults have suboptimal vitamin D levels [15]. Beyond bone health, vitamin D influences mood, immune function, and fatigue, all of which intersect with perimenopausal symptoms. Your blood panel will tell you whether supplementation is needed and at what dose.
Vaginal estrogen and pelvic floor support
For genitourinary symptoms, topical vaginal estrogen is a targeted treatment with minimal systemic absorption that can be used even by many women for whom systemic HRT isn't appropriate [9]. A pelvic floor physiotherapist can address urinary symptoms, discomfort, and muscle dysfunction that often accompany the hormonal transition.
Cognitive behavioral therapy (CBT) and stress management
CBT has been shown in clinical trials to reduce the severity and impact of hot flashes, improve sleep quality, and help manage the mood symptoms of perimenopause. It is recommended by the UK's National Institute for Health and Care Excellence (NICE) as both a standalone and a complementary approach to managing menopausal symptoms [16]. Stress management matters here because chronic stress elevates cortisol, which amplifies nearly every perimenopausal symptom, from weight gain to insomnia to brain fog.
The long-term stakes: why this matters beyond symptoms
Perimenopause isn't just about managing discomfort. The hormonal changes of this transition have lasting implications for two of the leading causes of morbidity in women: cardiovascular disease and osteoporosis.
Estrogen is cardioprotective. It supports healthy cholesterol ratios, blood vessel elasticity, and insulin sensitivity. As estrogen declines, your cardiovascular risk profile shifts, often significantly. Heart disease is the leading cause of death in Swiss women, accounting for approximately 29% of female deaths [17], and the risk acceleration begins during the menopausal transition, not after it [11].
Similarly, bone density begins to decline during perimenopause and drops sharply in the years immediately following menopause [10]. The window for protective intervention (through exercise, nutrition, vitamin D, and in some cases HRT) is most effective when started early, before significant loss has occurred.
The Ahead advantage: from uncertainty to a clear answer
At Ahead, we believe you shouldn't have to wait years for answers. Our approach is designed to give you and your doctor something concrete to work with: not a single data point, but a comprehensive picture.
What a standard check-up typically includes vs. what Ahead provides
A standard hormone check usually involves only one or two markers, often just FSH, sometimes estradiol. Cycle timing is not always taken into account. The result is a snapshot so narrow it can easily read as "normal" even when your hormones are in active flux.
Ahead's Hormone blood test (Women) measures 9 key hormone markers, including estradiol, FSH, LH, progesterone, SHBG, DHEA-S, testosterone, and the LH/FSH ratio, giving a detailed view of your reproductive hormone landscape. When combined with our Advanced blood test (81 biomarkers covering thyroid function, metabolic health, inflammation, iron, and vitamin D), you get the full context that makes hormone results interpretable.
Which Ahead package is right for you?
| Package | Price | What's included |
|---|---|---|
| Ahead Advanced | CHF 2'490 | Full-body MRI + 80+ biomarker blood panel including longevity and gender-specific markers |
| Ahead Pro | CHF 3'549 | Advanced + brain analysis, hormones and vitamins panels, hip/knee scan |
| Hormone blood test (Women, add-on) | Included in Pro; available separately | 9 reproductive hormone markers |
Every result is reviewed by Swiss board-certified physicians and delivered with a personalized action plan and a video consultation with your doctor. The goal is not to diagnose perimenopause from a single test. It's to establish your personal baseline, identify patterns that warrant follow-up, and give your GP or gynecologist something concrete to work from. Ahead's results complement your existing care rather than replacing it.
Supplementary health insurers may cover part of the cost for Ahead's check-ups. For example, KPT's supplementary insurance 'Pulse' reimburses up to CHF 1,500 for Ahead Health services. Check your coverage here.
Conclusion
The hormonal shift of perimenopause is real, measurable, and often starts years before anyone thinks to look for it. Insomnia, fatigue, brain fog, mood changes, hot flashes, and weight shifts are not minor inconveniences to be explained away. They are signals from an endocrine system in transition, signals that deserve investigation.
If you're in your late 30s or 40s and something feels different, a hormone panel is a reasonable next step. Not because something is wrong, but because knowing where you are gives you the ability to act: with your doctor, with a clear plan, and in the window when things are still early and manageable. That window is exactly the right time to look.
Sources
- Harlow SD, Gass M, Hall JE, et al. (2012). Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Climacteric, 15(2), 105–114. https://pubmed.ncbi.nlm.nih.gov/22344196/
- World Health Organization (2022). Menopause — Key Facts. https://www.who.int/news-room/fact-sheets/detail/menopause
- Avis NE, Crawford SL, Greendale G, et al. (2015). Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine, 175(4), 531–539. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2110996
- Santoro N, Epperson CN, Mathews SB (2015). Menopausal symptoms and their management. Endocrinology and Metabolism Clinics of North America, 44(3), 497–515. https://pubmed.ncbi.nlm.nih.gov/26316239/
- Freedman RR (2014). Menopausal hot flashes: mechanisms, endocrinology, treatment. Journal of Steroid Biochemistry and Molecular Biology, 142, 115–120. https://doi.org/10.1016/j.jsbmb.2013.08.010
- Joffe H, Massler A, Sharkey KM (2010). Evaluation and management of sleep disturbance during the menopause transition. Seminars in Reproductive Medicine, 28(5), 404–421. https://pubmed.ncbi.nlm.nih.gov/20845239/
- Maki PM, Kornstein SG, Joffe H, et al. (2018). Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Journal of Women's Health, 27(9), 1151–1183. https://pubmed.ncbi.nlm.nih.gov/30179986/
- Weber MT, Maki PM, McDermott MP (2014). Cognition and mood in perimenopause: a systematic review and meta-analysis. Journal of Steroid Biochemistry and Molecular Biology, 142, 90–98. https://pubmed.ncbi.nlm.nih.gov/23583249/
- Portman DJ, Gass MLS (2014). Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Maturitas, 79(3), 349–354. https://doi.org/10.1016/j.maturitas.2014.07.013
- Karlamangla AS, Shieh A, Greendale GA, et al. (2022). Anti-Müllerian hormone as predictor of future and ongoing bone loss during the menopause transition. Journal of Bone and Mineral Research, 37(7), 1224–1232. https://doi.org/10.1002/jbmr.4525
- International Menopause Society (2024). Menopause and MHT in 2024: addressing the key controversies — an International Menopause Society White Paper. Climacteric. https://www.tandfonline.com/doi/full/10.1080/13697137.2024.2394950
- Avgerinos KI, Spyrou N, Bougioukas KI, Kapogiannis D (2018). Effects of creatine supplementation on cognitive function of healthy individuals: a systematic review of randomized controlled trials. Experimental Gerontology, 108, 166–173. https://pubmed.ncbi.nlm.nih.gov/29704637/
- Smith-Ryan AE, Cabre HE, Eckerson JM, Candow DG (2021). Creatine supplementation in women's health: a lifespan perspective. Nutrients, 13(3), 877. https://www.mdpi.com/2072-6643/13/3/877
- Chilibeck PD, Kaviani M, Candow DG, Zello GA (2017). Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis. Open Access Journal of Sports Medicine, 8, 213–226. https://pubmed.ncbi.nlm.nih.gov/29138605/
- Schmid A, Walther B (2013). Natural vitamin D content in animal products. Advances in Nutrition, 4(4), 453–462; and Guessous I, et al. (2012). Vitamin D levels and associated factors: a population-based study in Switzerland. Swiss Medical Weekly, 142, w13719. https://pubmed.ncbi.nlm.nih.gov/23188555/
- National Institute for Health and Care Excellence (NICE) (2024). Menopause: identification and management (NG23), updated guideline. https://www.nice.org.uk/guidance/ng23
- Swiss Federal Statistical Office (2022). Cause of death statistics. https://www.bfs.admin.ch/bfs/en/home/statistics/health/state-health/mortality-causes-death.html
Frequently asked questions

Growth Lead
Led commercial and strategy projects in Life Sciences and Global Public Health at McKinsey & Company, including work across commercial due diligence, market access, and growth strategies. Holds a Master's in Banking and Finance from the University of St. Gallen with a focus on data science and quantitative methods.

